Bristol Myers Squibb to Present Data Supporting its Cardiovascular Portfolio at the American College of Cardiology Annual Scientific Session Together With World Congress of Cardiology Pharmaceutical Investing
AbbVie Highlights Robust Gastroenterology Portfolio with New Analyses and Data in Inflammatory Bowel Diseases at the 18th Congress of European Crohn's and Colitis Organisation Pharmaceutical Investing
AbbVie Receives Positive CHMP Opinion for Upadacitinib for the Treatment of Adults with Moderate to Severe Crohn's Disease Pharmaceutical Investing
COMPASS Pathways plc to announce fourth quarter and year-end 2022 financial results on 28 February 2023 Psychedelics Investing
MiniMed 780G system demonstrates superiority over multiple daily injections with CGM for type 1 diabetes management at one-year in ADAPT study Medical Device Investing
Merck and Ridgeback Provide Update on EU Marketing Authorization Application for LAGEVRIO Life Science Investing
Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference Pharmaceutical Investing
Jamieson Wellness Inc. Reports Fourth Quarter and Full Year 2022 Financial Results Life Science Investing
Jamieson Wellness Inc. Announces Partnership with DCP Capital to Support Strategic Growth Plan in China Life Science Investing
BriaCell Reports Positive Survival Data in Advanced Metastatic Breast Cancer Pharmaceutical Investing
